Clinical trials
Biologics clinical trials
Below are recruiting biologics clinical trials, each written for real people, not researchers. We’re tracking 622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06456450Recruiting
Taiwan severe asthma biologic registry study
This study is creating a registry to track the long-term safety and effectiveness of biologic treatments for severe asthma in Taiwan. If you are taking a biologic like omalizumab, mepolizumab, or benralizumab, joining this registry helps doctors learn how well these medicines work over time.
TaichungAges 18 years+ - NCT06348719Recruiting
Robot vs. standard laparoscopy for early endometrial cancer
This trial compares two types of minimally invasive surgery (robot-assisted vs. conventional laparoscopy) for removing the uterus in people with early-stage, low- to intermediate-risk endometrial cancer. The goal is to see which approach offers the best value and outcomes.
LilleAges 18 years+ - NCT06293196Recruiting
Acupoint eye massage trial for healthy people
This study tests whether massaging acupoints around the eyes can improve eye health measurements. It is only for healthy people with no eye problems, recent surgeries, or caffeine before the test.
Wuhan, HubeiAges 18–80 - NCT05792007Recruiting
Study of bone marrow environment in childhood leukemia
This study looks at what the bone marrow “microenvironment” is like in children newly diagnosed with acute leukemia, to better understand the disease. It also compares leukemia samples to samples from children having certain orthopedic surgery.
ToursAges 1–15 - NCT01129297Recruiting
Severe obesity tissue study during surgery
This study collects small tissue samples during certain abdominal surgeries to better understand what drives severe obesity and related blood-sugar patterns. If you agree to the extra sampling, your information and samples may help researchers build a “biological atlas” that could guide future treatments.
Lille, NordAges 18–65 - NCT05169593RecruitingPhase 4
Prevent Crohn’s return after surgery: endoscopy-guided vs standard medicine
This study compares two ways to choose biologic (targeted) medicines after Crohn’s surgery to help stop Crohn’s from coming back in the bowel. It may help you avoid or delay repeat inflammation by adjusting treatment based on endoscopy findings.
Antwerp, AntwerpenAges 18–80 - NCT01252485Recruiting
Biology and outcome registry for acute leukemia patients
This is a research registry that collects information and lab/blood sample data to better understand what acute leukemia looks like biologically and how patients do over time. It may help future treatment decisions, but it does not describe testing a new drug.
GrazAges 18 years+ - NCT04372108Recruiting
Long-term safety study for ustekinumab vs other biologics
This study follows adults with Crohn’s disease or ulcerative colitis to compare the long-term safety of ustekinumab against other biologic medicines. It may help show how safe these treatments are over time, using medical records.
Houston, TexasAges 18 years+ - NCT04290000Recruiting
Share samples after CAR-T treatment at Montpellier hospital
This study collects and stores biological samples from people who have been treated with CAR-T cells at the University Hospital of Montpellier. Your samples can help researchers learn more about treatment effects and safety.
MontpellierAges 18 years+ - NCT04104529Recruiting
Research database for metabolic radiotherapy patients
This study creates a database of information and blood samples from patients receiving a type of treatment called metabolic radiotherapy for certain cancers, like thyroid, neuroendocrine, or prostate cancer. It aims to improve understanding and care for future patients.
Bordeaux, AquitaineAges 18 years+ - NCT03579875RecruitingPhase 2
Testing an inherited bone marrow transplant approach for rare blood disorders
This Phase 2 study tests a special “T-cell depleted” transplant plan for people with inherited bone marrow failure disorders (Fanconi anemia or T-Beta-thalassemia—or “TBD”). It may help restore healthy blood production while lowering the chance of certain transplant complications.
Minneapolis, MinnesotaAges Up to 65 years - NCT03810573Recruiting
Bone graft for spinal fusion surgery
This trial tests a new bone graft material to help bones in the lower spine fuse together after surgery. It may be an option for people with degenerative disc disease or a mild spinal slip.
Clayton, VictoriaAges 17–70 - NCT03394053Recruiting
Studying the causes of primary immunodeficiency disorders
This study looks at blood samples and genetic information from people with primary immunodeficiency (a condition where the immune system doesn't work properly), their relatives, and healthy volunteers. The goal is to learn more about what causes these disorders, which could help improve future treatments.
Washington D.C., District of ColumbiaAges 1 day–90 years - NCT07754786RecruitingPhase 3
Comparing a new eczema medicine with dupilumab
This study tests whether a new biologic medicine (IBI3027) works as well as an approved medicine (dupilumab) for treating moderate-to-severe eczema. If you join, you may receive one of the two treatments, and researchers will compare their effects on your skin and itching.
Guangzhou, GuangdongAges 18–75 - NCT02900040Recruiting
Kidney transplant database and blood sample access study
This trial is about setting up and using a kidney-transplant database linked to stored blood/tissue samples. It may help researchers better understand kidney transplant outcomes and improve future care.
LyonAges 18 years+ - NCT04119102RecruitingPhase 4
Duobrii added to biologic treatment for plaque psoriasis
This trial tests whether adding Duobrii (a prescription psoriasis lotion) on top of your current biologic treatment helps improve plaque psoriasis. It includes adults whose psoriasis is in a moderate range and who have already been on a biologic for at least 24 weeks.
East Windsor, New JerseyAges 18 years+ - NCT03875703Recruiting
Biology sample collection after routine vaccination
This study collects biological samples (like blood and/or other samples) after you get a routine vaccine. It helps researchers learn more about how vaccines affect the body.
CréteilAges 18 years+ - NCT04804878Recruiting
Cancer care program for adults to help manage cancer
This study is a general cancer care program for adults (and in some cases people at risk for cancer). It aims to improve how cancer care is organized and delivered, and you may benefit from extra care support through the program.
Atlanta, GeorgiaAges 18 years+ - NCT03989323Recruiting
Register to track cancer immune therapy and side effects
This study sets up a real-world patient database to follow people starting cancer immunotherapy and record immune-related side effects. You may help doctors better understand who gets these side effects and how they change over time.
BronAges 18 years+ - NCT05062421Recruiting
Study how well arthritis treatments keep working over time
This study looks at people with adult rheumatoid arthritis to see how long biological medicines and “JAK inhibitors” keep helping. It uses routine clinic follow-up records to understand how well treatment persists over time and how outcomes change.
SevilleAges 18 years+ - NCT04917705Recruiting
Blood and tissue tests to find markers in muscle and skin disease
This study looks for blood and tissue “biomarkers” (measurable clues in samples) to help diagnose and predict outcomes in inflammatory muscle diseases and systemic sclerosis (a skin/organ condition). If you’re being evaluated for myopathy or early scleroderma, it may help doctors sort out the cause and follow your health more closely.
Strasbourg, Bas-RhinAges 18 years+ - NCT05186623Recruiting
Personalized prediction for ulcerative colitis treatment response
This study builds a prediction model to estimate how people with ulcerative colitis may respond to certain medicines. It may help doctors choose the most effective treatment sooner.
SeoulAges 18–79 - NCT03669809Recruiting
Study of how body timing affects metabolism
This trial looks at how “biological rhythm” (your body’s timing over the day and night) relates to metabolism, or how your body processes energy. It may help researchers understand whether timing patterns affect health and metabolic functions.
Jinan, ShandongAges 18–30 - NCT04837339Recruiting
Testing markers to predict problems after lung transplant
This study looks for lab “clues” that can help predict how well someone’s lungs will do after a lung transplant. It may help doctors spot transplant-related problems earlier so care can be planned sooner.
SuresnesAges 15 years+
Hear when a new Biologics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for biologics?
- Yes. Clin2 currently lists 622 recruiting biologics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biologics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biologics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.